4.5 Review

New Options in Constipation Management

期刊

CURRENT ONCOLOGY REPORTS
卷 17, 期 12, 页码 -

出版社

SPRINGER
DOI: 10.1007/s11912-015-0481-x

关键词

Constipation; Probiotics; Prokinetics; Lubiprostone; Linaclotide; Transporter; Mu receptor; Antagonist

类别

向作者/读者索取更多资源

Constipation is common in the general population and for those on opioids and/or who are suffering from advanced cancer. Self-management consists of dietary changes, exercise, and laxatives. However, responses to selfmanagement efforts are often inadequate to relieve the subjective and objective experience of constipation. Multiple new anti-constipating medications have recently been tested in randomized trials and the following are available commercially: probiotics, prucalopride, lubiprostone, linaclotide, elobixibat, antidepressants, methylnaltrexone, alvimopan, and naloxegol. This review will discuss the evidence-based benefits of these medications and outline an approach to managing constipation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据